Semaglutide-Induced Weight Loss and Metabolic Changes in Bangladeshi Adults with Obesity: A Prospective Study in Diabetic and Non-Diabetic Populations
Background: Obesity and type 2 diabetes mellitus (T2DM) are escalating public health crises in Bangladesh, yet real-world pharmacotherapy data remain scarce. Glucagon-like peptide-1 receptor agonists, particularly semaglutide, have demonstrated substantial weight loss and metabolic benefits in global trials, but prospe...